What it is
MK-677 at a glance
Ibutamoren; oral ghrelin receptor agonist, not a peptide
Raises GH and IGF-1 in studies; examined for frailty and body composition, but edema, insulin resistance, and appetite effects matter.
View supplier listing
10% off with code IRONMAN
Peptide guide
MK-677 Peptide Guide & Supplier Listing Notes
Ibutamoren; oral ghrelin receptor agonist, not a peptide
Raises GH and IGF-1 in studies; examined for frailty and body composition, but edema, insulin resistance, and appetite effects matter.
Educational disclaimer
Informational reference only
This page is for educational and informational purposes only. PeptideSuppliers.org does not sell peptides, provide medical advice, or recommend human use.
Research context
Where current research places it
GH/IGF-1 axis, frailty, sleep, body composition research
Human clinical research; investigational, non-peptide
Research overview
Use the linked literature searches for current papers and trial records.
Current summary
What research has looked at
Raises GH and IGF-1 in studies; examined for frailty and body composition, but edema, insulin resistance, and appetite effects matter.
Evidence stage
How mature the research is
Human clinical research; investigational, non-peptide
Source links
Open current literature searches
Mechanism
An oral alternative with real tradeoffs
MK-677 (ibutamoren) is an orally active, non-peptide ghrelin receptor agonist that raises GH and IGF-1 levels without requiring injection, which is a major reason it has been heavily researched in frailty, sleep, and body-composition contexts.
That convenience comes with tradeoffs that studies consistently flag: increased appetite, fluid retention, and reduced insulin sensitivity are recurring findings alongside its GH and IGF-1-raising effects, and those tradeoffs are central to how researchers evaluate the compound.
Storage and handling notes
What clear supplier pages show
These pages are easier to trust when storage notes are easy to find, the format is clearly labeled, and batch documentation stays close to the listing.
- Check whether the page clearly states the compound format being referenced.
- Look for storage language that matches the label and any linked laboratory documentation.
- Compare whether lot, batch, or COA references remain easy to access after the product details.
- Note whether the page explains container, seal, or light-protection details in plain language.
Choosing a supplier page
What to compare when opening listings
The clearest MK-677 listings explain the directory context and keep documentation notes visible enough to compare with neighboring entries.
MK-677 pages read better when they acknowledge the peptide-adjacent labeling and focus on category clarity, batch context, and research-use wording.
Linked supplier pages
Use these pages to compare naming, documentation access, and overall page clarity.
Supplier listing
Iron Peptides
This listing is useful for checking naming, documentation access, and overall page clarity.
10% off with code IRONMANRelated peptides
Use related pages to compare nearby compounds and adjacent research categories.
Frequently asked questions
Quick answers to the main questions that come up on this page.
What is MK-677?
Ibutamoren; oral ghrelin receptor agonist, not a peptide
What research areas is it linked to?
GH/IGF-1 axis, frailty, sleep, body composition research
Human clinical research; investigational, non-peptide
What should stand out when comparing supplier pages?
The clearest MK-677 listings explain the directory context and keep documentation notes visible enough to compare with neighboring entries.
Is MK-677 a peptide?
No. It is a small molecule, even though it is commonly discussed alongside injectable GH secretagogue peptides because it produces similar downstream effects on GH and IGF-1.
What are the main tradeoffs studied with MK-677?
Increased appetite, water retention, and reduced insulin sensitivity are recurring findings alongside its GH/IGF-1-raising effects.